[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361846-105":59,"doc-detail-361846-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","emerging-nanotechnologies-and-their-role-in-early-ovarian-cancer-detection-diagnosis-and-interventions","Emerging nanotechnologies and their role in early ovarian cancer detection, diagnosis and interventions","","Ovarian cancer poses a major public health challenge, with many cases diagnosed at advanced stages due to current detection limitations. This systematic review evaluates recent nanotechnology advances aimed at improving early detection and diagnosis, comparing nanotech strategies with traditional diagnostic approaches. Evidence spans nanoparticles, biosensors, advanced imaging, and biomarker detection platforms, assessing detection rates, turnaround times, and accuracy for cancer versus non-cancer discrimination. Nanotechnology-based methods show high sensitivity and specificity, with reported detection rates exceeding 90% for early-stage cancers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/emerging-nanotechnologies-and-their-role-in-early-ovarian-cancer-detection-diagnosis-and-interventions/361846/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/emerging-nanotechnologies-and-their-role-in-early-ovarian-cancer-detection-diagnosis-and-interventions/361846.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is early detection of ovarian cancer difficult with current methods?","Question",{"text":112,"@type":113},"Early detection is hindered by limitations in existing approaches, leading to many diagnoses at advanced stages. Current practices such as transvaginal ultrasound and serum CA-125 testing have insufficient sensitivity and specificity, producing false positives and negatives.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What types of nanotechnology approaches are reviewed?",{"text":117,"@type":113},"The review covers nanoparticles, biosensors, advanced imaging techniques, and biomarker detection platforms. It evaluates how these approaches distinguish cancerous from non-cancerous tissues.",{"name":119,"@type":110,"acceptedAnswer":120},"What performance indicators does the review emphasize?",{"text":121,"@type":113},"The review focuses on detection rates, turnaround times, and accuracy. It highlights sensitivity and specificity reported in studies for identifying ovarian cancer biomarkers.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},361846,1791913939,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Oyowvi et al. Journal of Ovarian Research (2025) 18:96 Journal of Ovarian Research  \n[https://doi.org/10.1186/s13048-025-01678-3](https://doi.org/10.1186/s13048-025-01678-3)  \nREVIEW Open Access  \nEmerging nanotechnologies and their role in early ovarian cancer detection, diagnosis and interventions  \nMega Obukohwo Oyowvi 1,2*, Kehinde Henrietta Babawale 1, Adedeji David Atere3,4 and Benneth Ben-Azu5  \nAbstract  \nOvarian cancer presents a significant public health challenge, often being diagnosed at advanced stages due to the limitations of current detection methods. This systematic review addresses the urgent need for innovative approaches to enhance early detection and diagnosis of ovarian cancer. We systematically evaluate recent advancements in nanotechnology, focusing specifically on their novel applications and potential in comparison to traditional diagnostic modalities. Our analysis encompasses a wide range of studies investigating nanoparticles, biosensors, advanced imaging techniques, and biomarker detection platforms, with an emphasis on evaluating key performance indicators such as detection rates, turnaround times, and the accuracy of distinguishing cancerous from non-cancerous tissues. Our findings indicate that nanotechnology-based approaches have the potential to significantly improve early detection capabilities for ovarian cancer. Notably, studies on nanoparticle-based imaging techniques and biosensors consistently demonstrate high sensitivity and specificity for identifying ovarian cancer biomarkers, with detection rates exceeding 90% reported for early-stage cancers in several instances. This review underscores the promise of emerging nanotechnologies to transform the landscape of early detection and diagnosis, offering a pathway toward earlier diagnoses, enhanced therapeutic interventions, and improved patient outcomes. We advocate for future research dedicated to the translational efforts required to move these technologies from bench to bedside, ensuring their effectiveness is validated across diverse clinical populations.  \nClinical trial number  \nNot applicable.  \nKeywords Ovarian cancer, Nanocarriers, Nanoparticles, Biosensors, Biomarkers, Imaging techniques  \n*Correspondence:  \nMega Obukohwo Oyowvi  \n[megalect@gmail.com](megalect@gmail.com)  \n1Department of Physiology, Adeleke University, Ede, Osun State, Nigeria 2Department of Physiology, Delta State University of Science and Technology, Ozoro, Delta State, Nigeria  \n3Department of Medical Laboratory Science, College of Health Sciences, Osun State University, Osogbo, Nigeria  \n4Neurotoxicology Laboratory, Sefako Makgatho Health Sciences University, Molotlegi St, Ga-Rankuwa Zone 1, Ga-Rankuwa  \n0208, South Africa  \n5DELSU Joint Canada-Israel Neuroscience and Biopsychiatry Laboratory, Department of Pharmacology, Delta State University, Abraka, Delta State, Nigeria  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nOyowvi et al. Journal o","cbCaivdcIWAExNJ8","https://ap.wps.com/l/cbCaivdcIWAExNJ8","pdf",1879375,"English","# Introduction\n# Nanotechnology and its diagnostic potential\n# Review scope and evaluation criteria\n# Findings on detection performance\n# Clinical translation and future research","[{\"question\":\"Why is early detection of ovarian cancer difficult with current methods?\",\"answer\":\"Early detection is hindered by limitations in existing approaches, leading to many diagnoses at advanced stages. Current practices such as transvaginal ultrasound and serum CA-125 testing have insufficient sensitivity and specificity, producing false positives and negatives.\"},{\"question\":\"What types of nanotechnology approaches are reviewed?\",\"answer\":\"The review covers nanoparticles, biosensors, advanced imaging techniques, and biomarker detection platforms. It evaluates how these approaches distinguish cancerous from non-cancerous tissues.\"},{\"question\":\"What performance indicators does the review emphasize?\",\"answer\":\"The review focuses on detection rates, turnaround times, and accuracy. It highlights sensitivity and specificity reported in studies for identifying ovarian cancer biomarkers.\"}]","Emerging nanotechnologies and their role in early ovarian cancer detection, diagnosis and interventions | PDF",1790145787,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/deb215d9370bc007895c3a97ecd73f8c.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39aaaa04f29c17709a9a590597d5e48c.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/451c471b3a06984f6d2d2736174543f2.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae947a9214167d0dc029836c8a5b55b2.webp",980,1306]